tiprankstipranks
Trending News
More News >
Structure Therapeutics, Inc. Sponsored ADR (GPCR)
NASDAQ:GPCR
US Market
Advertisement

Structure Therapeutics, Inc. Sponsored ADR (GPCR) Ownership - Who Owns Structure Therapeutics, Inc. Sponsored ADR?

Compare
1,017 Followers

Structure Therapeutics, Inc. Sponsored ADR (GPCR) Ownership Overview

11.96%30.98%<0.01%0.93%56.12%
11.96% Insiders
<0.01% Other Institutional Investors
0.93% ETFs
56.12% Public Companies and
Individual Investors
The ownership structure of Structure Therapeutics, Inc. Sponsored ADR (GPCR) stock is a mix of institutional, retail, and individual investors. Approximately 31.91% of the company’s stock is owned by Institutional Investors, 11.96% is owned by Insiders, and 56.12% is owned by Public Companies and Individual Investors.
The ownership structure of Structure Therapeutics, Inc. Sponsored ADR (GPCR) stock is a mix of institutional, retail, and individual investors. Approximately 30.98% of the company’s stock is owned by Institutional Investors, 11.96% is owned by Insiders, and 0.93% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Mar 31, 2025
xxxxxxxxxxxxx
$73515
Mar 31, 2025
xxxxxxxxxxxxx
$206127
Mar 31, 2025
xxxxxxxxxxxxx
$521065
Mar 31, 2025
xxxxxxxxxxxxx
$3036589

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
4,414,573Institution7.67%84,892,239
3,800,961Institution6.61%73,092,480
2,874,462Insider5.00%55,275,904
2,749,416Insider4.78%52,871,270
1,517,418Institution2.64%29,179,948
1,458,288Institution2.53%28,042,878
1,272,743Institution2.21%24,474,848
1,022,281Institution1.78%19,658,464
929,176Institution1.61%17,868,054
791,500Institution1.38%15,220,545

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
4,414,573Institution7.67%84,892,239
3,800,961Institution6.61%73,092,480
1,458,288Institution2.53%28,042,878
1,022,281Institution1.78%19,658,464
929,176Institution1.61%17,868,054
791,500Institution1.38%15,220,545
593,086Institution1.03%11,405,044
582,447Institution1.01%11,200,456
450,000Institution0.78%8,653,500
385,871Institution0.67%7,420,299

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
208,440Institution0.36%4,008,301
61,732Institution0.11%1,208,095
41,336Institution0.07%715,526
37,765Institution0.07%818,745
34,883Institution0.06%682,660
28,143Institution0.05%541,190
22,368Institution0.04%437,742
16,641Institution0.03%362,108
15,000Institution0.03%585,063
6,859Institution0.01%130,390

FAQ

Who Owns Structure Therapeutics, Inc. Sponsored ADR (GPCR)?
According to the latest TipRanks data, approximately <0.01% of the company's stock is held by institutional investors, 11.96% is held by insiders, and 56.12% is held by retail investors.
    What percentage of Structure Therapeutics, Inc. Sponsored ADR (GPCR) stock is held by institutional investors?
    According to the latest TipRanks data, approximately <0.01% of Structure Therapeutics, Inc. Sponsored ADR (GPCR) stock is held by institutional investors.
      What percentage of Structure Therapeutics, Inc. Sponsored ADR (GPCR) stock is held by retail investors?
      According to the latest TipRanks data, approximately 56.12% of Structure Therapeutics, Inc. Sponsored ADR (GPCR) stock is held by retail investors.
        Who owns the most shares of Structure Therapeutics, Inc. Sponsored ADR (GPCR)?
        VANGUARD SPECIALIZED FUNDS owns the most shares of Structure Therapeutics, Inc. Sponsored ADR (GPCR).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis